hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.

Welcome to VIROBLOG from hVIVO. With a wealth of medical and scientific knowledge within the hVIVO business, and a vast  amount of qualified experience in the development and use of human challenge models, we are now committed to making our VIROBLOG a regular feature of our community outreach with regular opinion led items and commentary on issues affecting the drug development, medical research and respiratory disease subject areas.

Please sign-up to follow our VIROBLOG. We encourage comments and interaction. And don’t forget to connect with us on our other social media properties. Whilst VIROBLOG is purposed for more considered articles and scientific discussion going forward, our hVIVO Twitter, Facebook, Linkedin and Google+ communities are available for more regular news updates and “soundbites” from in and around our sector.



January 29, 2016 10:16 am

Germany Confirms Five Zika Virus Cases


Published by

January 28, 2016 12:15 pm

WHO leader: Zika virus ‘spreading explosively’


Published by

January 9, 2016 9:13 am

Beware Influenza, The Silent Killer – Forbes


Published by

January 2, 2016 9:10 am

China reports human H7N9 avian influenza infection in Shanghai man | Outbreak News Today


Published by

December 22, 2015 9:06 am

‘top trending health symptom on Google in 2015’

Published by

December 18, 2015 10:05 am

Mers virus vaccine ‘a step closer’

Mers virus vaccine ‘a step closer’ BBC NEWS – SCIENCE & ENVIRONMENT | 18 DECEMBER 2015 http://pulse.me/s/5miCA4 An effective vaccine... View Article

Published by

December 18, 2015 9:46 am

Vaxart Announces Enrollment of First Patient in Influenza B Phase 1 Trial | Vaccines | News Channels


Published by

December 2, 2015 8:25 am

Motavizumab reduces RSV hospitalizations in Native American infants


Published by

November 26, 2015 1:42 pm

Influenza-Associated Excess Mortality in South Korea


Published by

November 26, 2015 1:32 pm

Press Announcements > FDA approves first seasonal influenza vaccine containing an adjuvant


Published by

Search Blog



Featured Tags